Showing results (281-290 of 419) with videos related to

Sort By:
Pageof 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapyO N Koç, S L Gerson, B W Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocolC R Nichols, J Andersen, H M Lazarus, et al.
Leukemia & Lymphoma|May 9, 2001
Lowering the prophylactic platelet transfusion threshold: a prospective analysisJ B Lawrence, R A Yomtovian, T Hammons, et al.
Leukemia|October 1, 1992
Phase II clinical trial of carboplatin in relapsed and refractory leukemiaW R Vogler, D P Harrington, E F Winton, et al.
American Journal of Hematology|February 1, 1995
Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysisN Blumberg, J M Heal, S A Kirkley, et al.
International Journal of Antimicrobial Agents|July 1, 1996
Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patientsH M Lazarus, R J Creger, R Gucalp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2000
Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factorD P Schenkein, Y Koc, T Alcindor, et al.
The American Journal of Medicine|December 1, 1984
Successful thrombolytic therapy in two patients with renal vein thrombosisJ M Rowe, R L Rasmussen, S L Mader, et al.
Pageof 42